<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03142711</url>
  </required_header>
  <id_info>
    <org_study_id>AMP-003</org_study_id>
    <nct_id>NCT03142711</nct_id>
  </id_info>
  <brief_title>Validation of a Mobile Phone Based on EPRO Tool in Subjects With Systemic Lupus Erythematosus</brief_title>
  <acronym>VALUE</acronym>
  <official_title>Validation of a Mobile Phone Based on EPRO Tool in Subjects With Systemic Lupus Erythematosus</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Lupus Research Alliance</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Pfizer</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
    <collaborator>
      <agency>Ampel BioSolutions, LLC</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Lupus Research Alliance</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Systemic lupus erythematosus (SLE) may involve a variety of organ systems expressed
      differently from patient to patient, and so can be difficult to characterize clinically.
      Patient reported outcomes (PROs), which consist of feedback directly from patients regarding
      their symptoms without interpretation by a clinician, are typically used in SLE to supplement
      other clinical measures. Standard PROs typically used in SLE include the 36-item short form
      health survey (SF-36), the functional assessment of chronic illness therapy - fatigue
      (FACIT-F), and the patient global assessment (PtGA), administered by paper or electronic
      tablet during the clinic visits. The recent development of electronic mobile device
      technology, such as the smartphone, has made it possible to collect PRO information away from
      the clinical site in the subject's environment. This study will assess by measurement
      equivalence testing whether data collected via a smartphone are comparable to that collected
      in standard fashion and whether PROs obtained in the subject's environment may be more
      informative than that collected in the physician's office on paper.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">August 21, 2017</start_date>
  <completion_date type="Anticipated">May 2018</completion_date>
  <primary_completion_date type="Anticipated">March 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>ePRO Validation</measure>
    <time_frame>7 months</time_frame>
    <description>To evaluate measurement equivalence between the two PRO data collection modes - original paper mode versus the ePRO application on a handheld mobile phone for the following PRO's: SF-36 HRQoL questionnaire, the FACIT-F fatigue instrument, and the PtGA. The three PROs will be administered on clinic days by both modes: paper and ePRO. Concurrent results will be compared, and percentage similarities calculated.</description>
  </primary_outcome>
  <enrollment type="Anticipated">80</enrollment>
  <condition>SLE</condition>
  <condition>Lupus Erythematosus, Systemic</condition>
  <condition>Systemic Lupus Erythematosus</condition>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>No Medical Intervention</intervention_name>
    <description>Validation of phone ePRO</description>
  </intervention>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Blood and Urine samples
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with SLE.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Willing and able to provide written informed consent

          2. Males or females, aged 18 years or older

          3. Classification of SLE by either the American College of Rheumatology (ACR) or Systemic
             Lupus International Collaborating Clinics Classification (SLICC) criteria

          4. On a stable SLE treatment regimen consisting of any of the following medications for a
             period of at least 30 days prior to Screening

               -  Corticosteroids (&lt;30 mg prednisone or equivalent per day)

               -  Hydroxychloroquine or equivalent anti-malarial

               -  Other immunosuppressive or immunomodulatory agents including methotrexate,
                  azathioprine, leflunomide, mycophenolate (including mycophenolate mofetil or
                  sodium), cyclophosphasmide, belimumab, calcineurin inhibitors (e.g. tacrolimus,
                  cyclosporine)

          5. Willing to perform and comply with all study procedures, including attending clinic
             visits at Baseline, Month 1, and Month 2 as scheduled

        Exclusion Criteria:

          1. Rapidly progressive neurologic disease

          2. Cognitive dysfunction that might interfere with the capacity to use the ePRO device

          3. Any condition that might in the investigator's opinion might preclude completion of
             the study

          4. Current drug or alcohol abuse or dependence, or a history of drug or alcohol abuse or
             dependence within 1 year prior to Screening

          5. Clinical evidence of significant unstable or uncontrolled acute or chronic diseases
             not caused by SLE (e.g., diabetes, cardiovascular, pulmonary, hematologic,
             gastrointestinal, neurological, or infectious) which, in the opinion of the
             Investigator, could confound the results of the study or put the subject at undue
             risk.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Claire Dykas</last_name>
    <phone>434-977-2675</phone>
    <email>claire.dykas@ampelbiosolutions.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Emory University</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30303</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sam Lim</last_name>
      <phone>404-616-5480</phone>
      <email>sslim@emory.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Brigham and Women's HospitL</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02115</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Elena Massarotti</last_name>
      <phone>617-732-6523</phone>
      <email>emassarotti@partners.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Northwell Health</name>
      <address>
        <city>Great Neck</city>
        <state>New York</state>
        <zip>11021</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Richard Furie</last_name>
      <phone>516-708-2550</phone>
      <email>rfurie@nshs.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Allegheny Health Network</name>
      <address>
        <city>Pittsburgh</city>
        <state>Pennsylvania</state>
        <zip>15212</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Susan Manzi</last_name>
      <phone>412-359-3022</phone>
      <email>smanzi@wpahs.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Vanderbilt University Medical Center</name>
      <address>
        <city>Nashville</city>
        <state>Tennessee</state>
        <zip>37232</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Narender Annapureddy</last_name>
      <phone>615-936-4073</phone>
      <email>narender.annapureddy@vanderbilt.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of Alberta</name>
      <address>
        <city>Edmonton</city>
        <state>Alberta</state>
        <zip>T6G 2S2</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Stephanie Keeling</last_name>
      <phone>780-407-7540</phone>
      <email>stephanie.keeling@ualberta.ca</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of Manitoba</name>
      <address>
        <city>Winnipeg</city>
        <state>Manitoba</state>
        <zip>R3A 1M4</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christine Peschken</last_name>
      <phone>204-787-1851</phone>
      <email>christine.peschken@umanitoba.ca</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>McMaster University Medical Centre</name>
      <address>
        <city>Hamilton</city>
        <state>Ontario</state>
        <zip>L8S 4K1</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mark Matsos</last_name>
      <phone>905-521-9034</phone>
      <email>matsosmp@mcmaster.ca</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of Western Ontario/St. Joseph's Healthcare</name>
      <address>
        <city>London</city>
        <state>Ontario</state>
        <zip>N6A 4V2</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Janet Pope</last_name>
      <phone>519-646-6332</phone>
      <email>janet.pope@sjhc.london.on.ca</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>McGill University Health Centre</name>
      <address>
        <city>Montr√©al</city>
        <state>Quebec</state>
        <zip>H3G 1A4</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christian Pineau</last_name>
      <phone>514-934-1934</phone>
      <email>christian.pineau@mcgill.ca</email>
    </contact>
  </location>
  <location_countries>
    <country>Canada</country>
    <country>United States</country>
  </location_countries>
  <verification_date>January 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 3, 2017</study_first_submitted>
  <study_first_submitted_qc>May 4, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">May 5, 2017</study_first_posted>
  <last_update_submitted>January 11, 2018</last_update_submitted>
  <last_update_submitted_qc>January 11, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">January 16, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lupus Erythematosus, Systemic</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

